Since severe COVID‐19 has a highly impaired IFN type I signature, with especially reduced IFN‐α production and activity [16], we initially asked how the major effector downstream targets of type I IFN are affected among patients with COVID‐19. Here, IFNA2 is linked to COVID-19.